Variant report
Variant | nsv979350 |
---|---|
Chromosome Location | chr2:186647975-186654591 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:51)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr2:186650918-186651197 | GM12878 | blood: | n/a | chr2:186651050-186651061 |
2 | BATF | chr2:186650911-186651150 | GM12878 | blood: | n/a | chr2:186651050-186651061 |
3 | CHD1 | chr2:186651270-186651353 | GM12878 | blood: | n/a | n/a |
4 | CHD2 | chr2:186651414-186651424 | GM12878 | blood: | n/a | n/a |
5 | CUX1 | chr2:186650793-186651412 | GM12878 | blood: | n/a | chr2:186651337-186651346 |
6 | E2F4 | chr2:186652308-186652616 | MCF10A-Er-Src | breast: | n/a | chr2:186652475-186652484 |
7 | EBF1 | chr2:186650586-186651490 | GM12878 | blood: | n/a | n/a |
8 | EP300 | chr2:186652104-186652669 | SK-N-SH | brain: | n/a | n/a |
9 | EP300 | chr2:186649764-186650281 | SK-N-SH_RA | brain: | n/a | chr2:186650080-186650094 |
10 | EP300 | chr2:186652322-186652614 | SK-N-SH_RA | brain: | n/a | n/a |
11 | EP300 | chr2:186650754-186651089 | GM12878 | blood: | n/a | chr2:186650808-186650822 chr2:186650809-186650818 |
12 | EP300 | chr2:186649832-186650284 | SK-N-SH_RA | brain: | n/a | chr2:186650080-186650094 |
13 | EP300 | chr2:186652357-186652627 | SK-N-SH_RA | brain: | n/a | n/a |
14 | EP300 | chr2:186650813-186651136 | GM12878 | blood: | n/a | n/a |
15 | EP300 | chr2:186650543-186651455 | GM12878 | blood: | n/a | chr2:186651317-186651325 chr2:186650808-186650822 chr2:186650809-186650818 |
16 | FOS | chr2:186650868-186651181 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOS | chr2:186650897-186651221 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOS | chr2:186652201-186652662 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FOS | chr2:186652035-186652660 | HUVEC | blood vessel: | n/a | chr2:186652096-186652104 chr2:186652094-186652106 |
20 | FOS | chr2:186650949-186651185 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | FOS | chr2:186651923-186652642 | MCF10A-Er-Src | breast: | n/a | chr2:186652096-186652104 chr2:186652094-186652106 |
22 | FOS | chr2:186652267-186652846 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr2:186650845-186651250 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | FOS | chr2:186652235-186652640 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | FOSL1 | chr2:186652226-186652619 | HCT-116 | colon: | n/a | n/a |
26 | FOSL1 | chr2:186652169-186652731 | HCT-116 | colon: | n/a | n/a |
27 | FOSL2 | chr2:186650848-186651290 | SK-N-SH | brain: | n/a | n/a |
28 | FOSL2 | chr2:186652172-186652591 | SK-N-SH | brain: | n/a | n/a |
29 | GATA3 | chr2:186652154-186652826 | SK-N-SH | brain: | n/a | n/a |
30 | GATA3 | chr2:186652152-186652741 | SK-N-SH | brain: | n/a | n/a |
31 | JUND | chr2:186652184-186652683 | SK-N-SH | brain: | n/a | n/a |
32 | MAFK | chr2:186649525-186649759 | HepG2 | liver: | n/a | n/a |
33 | NFIC | chr2:186650631-186651257 | GM12878 | blood: | n/a | n/a |
34 | NFIC | chr2:186652327-186652599 | SK-N-SH | brain: | n/a | chr2:186652488-186652504 |
35 | NFIC | chr2:186650583-186651290 | GM12878 | blood: | n/a | n/a |
36 | NFIC | chr2:186652120-186652849 | SK-N-SH | brain: | n/a | chr2:186652488-186652504 |
37 | PBX3 | chr2:186652173-186652639 | SK-N-SH | brain: | n/a | n/a |
38 | POLR2A | chr2:186652060-186652237 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | POLR2A | chr2:186650130-186650255 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | POLR2A | chr2:186648683-186648715 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | POLR2A | chr2:186652303-186652571 | SK-N-SH | brain: | n/a | n/a |
42 | RCOR1 | chr2:186650840-186651391 | GM12878 | blood: | n/a | n/a |
43 | RUNX3 | chr2:186650589-186651415 | GM12878 | blood: | n/a | n/a |
44 | SPI1 | chr2:186650404-186651277 | GM12878 | blood: | n/a | chr2:186650813-186650822 chr2:186650807-186650820 |
45 | SPI1 | chr2:186650697-186650910 | GM12878 | blood: | n/a | chr2:186650813-186650822 chr2:186650807-186650820 |
46 | SPI1 | chr2:186650601-186650885 | GM12878 | blood: | n/a | chr2:186650813-186650822 chr2:186650807-186650820 |
47 | SPI1 | chr2:186650608-186650929 | GM12891 | blood: | n/a | chr2:186650813-186650822 chr2:186650807-186650820 |
48 | SPI1 | chr2:186650563-186650894 | GM12891 | blood: | n/a | chr2:186650813-186650822 chr2:186650807-186650820 |
49 | STAT3 | chr2:186650976-186651015 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | STAT3 | chr2:186650942-186651127 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:186650871..186652540-chr2:186657235..186659322,2 | K562 | blood: |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZSWIM2-5 | chr2:186653493-186653670 | ENSG00000231646.1 |
2 | lnc-ZSWIM2-5 | chr2:186653493-186653670 | ENSG00000231646.1 |
3 | lnc-ZSWIM2-5 | chr2:186648418-186648857 | ENSG00000231646.1 |
4 | lnc-ZSWIM2-5 | chr2:186652747-186652936 | ENSG00000231646.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
FSIP2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572415986 | chr2:186647982-186647983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368445672 | chr2:186647985-186647986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78585053 | chr2:186648013-186648014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563559257 | chr2:186648015-186648016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546388481 | chr2:186648069-186648070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576903685 | chr2:186648075-186648076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541373156 | chr2:186648129-186648130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376779396 | chr2:186648154-186648155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185810431 | chr2:186648158-186648159 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371054120 | chr2:186648188-186648189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571062493 | chr2:186648199-186648200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541663438 | chr2:186648244-186648245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs147382646 | chr2:186648306-186648307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148438123 | chr2:186648342-186648343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552251499 | chr2:186648384-186648385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564169984 | chr2:186648424-186648425 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs528450159 | chr2:186648462-186648463 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs532345920 | chr2:186648468-186648469 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs114438088 | chr2:186648469-186648470 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs563708792 | chr2:186648519-186648520 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs150521841 | chr2:186648552-186648553 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs541021776 | chr2:186648557-186648558 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs536097106 | chr2:186648576-186648577 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs550903719 | chr2:186648640-186648641 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs76503298 | chr2:186648669-186648670 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs139601771 | chr2:186648743-186648744 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs558662977 | chr2:186648794-186648795 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs190221619 | chr2:186648796-186648797 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs534625065 | chr2:186648835-186648836 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs183814791 | chr2:186648852-186648853 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs188406147 | chr2:186648895-186648896 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191631911 | chr2:186648918-186648919 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11883784 | chr2:186648974-186648975 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs545926087 | chr2:186648975-186648976 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs80137114 | chr2:186648984-186648985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564254321 | chr2:186649025-186649026 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149746522 | chr2:186649091-186649092 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183978466 | chr2:186649117-186649118 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187620892 | chr2:186649121-186649122 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546097499 | chr2:186649126-186649127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561060188 | chr2:186649175-186649176 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146717446 | chr2:186649207-186649208 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551251855 | chr2:186649245-186649246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569378059 | chr2:186649270-186649271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs191428319 | chr2:186649271-186649272 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551976776 | chr2:186649333-186649334 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570565231 | chr2:186649343-186649344 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs183567214 | chr2:186649568-186649569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs35677317 | chr2:186649594-186649595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530165223 | chr2:186649666-186649667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186647800-186648600 | Weak transcription | Fetal Intestine Large | intestine |
2 | chr2:186648000-186648200 | Enhancers | Rectal Mucosa Donor 29 | rectum |
3 | chr2:186648200-186670400 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
4 | chr2:186648600-186648800 | Enhancers | Sigmoid Colon | Sigmoid Colon |
5 | chr2:186648600-186649400 | Enhancers | Fetal Intestine Large | intestine |
6 | chr2:186648800-186658000 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
7 | chr2:186650400-186651600 | Enhancers | GM12878-XiMat | blood |
8 | chr2:186650400-186653400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr2:186650600-186652400 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr2:186651200-186651600 | Enhancers | NHDF-Ad | bronchial |
11 | chr2:186651600-186652400 | Weak transcription | NHDF-Ad | bronchial |
12 | chr2:186651600-186654800 | Weak transcription | GM12878-XiMat | blood |
13 | chr2:186652000-186652600 | Enhancers | NH-A | brain |
14 | chr2:186652000-186653000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr2:186652000-186661400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
16 | chr2:186652200-186652600 | Enhancers | HUVEC | blood vessel |
17 | chr2:186652400-186652600 | Enhancers | NHDF-Ad | bronchial |
18 | chr2:186652600-186657800 | Weak transcription | NHDF-Ad | bronchial |